Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
cancer
6
×
life sciences
national blog main
national top stories
startups
6
×
venture capital
6
×
san diego blog main
san diego top stories
san francisco blog main
boston blog main
deals
ipo
new york blog main
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
innovation
laura shawver
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
vc
wisconsin blog main
wisconsin top stories
astrazeneca
avalon ventures
biogen
boston top stories
What
bio
drugs
ipo
roundup
advance
biology
covid
cytokine
developing
enhanced
fda
help
medicines
new
plans
raises
san
suite
synthetic
synthorx
technology
acquisitions
activity
agent
ahead
announced
approvals
asco
better
biogen
biologic
branded
ceo
choices
clamped
collabs
commissioner
company
consumers
costly
Language
unset
Current search:
cancer
×
startups
×
" venture capital "
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs